AstraZeneca PLC
NASDAQ:AZN

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
NASDAQ:AZN
Watchlist
Price: 78.02 USD -0.37% Market Closed
Market Cap: 241.9B USD
Have any thoughts about
AstraZeneca PLC?
Write Note

AstraZeneca PLC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AstraZeneca PLC
Capital Expenditures Peer Comparison

Comparables:
GSK
INDV
HIK
DPH
A
APH

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
AstraZeneca PLC
LSE:AZN
Capital Expenditures
-$4.1B
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
-3%
GlaxoSmithKline PLC
LSE:GSK
Capital Expenditures
-ÂŁ2.3B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Indivior PLC
LSE:INDV
Capital Expenditures
-$52m
CAGR 3-Years
-14%
CAGR 5-Years
-24%
CAGR 10-Years
-6%
Hikma Pharmaceuticals PLC
LSE:HIK
Capital Expenditures
-$205m
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Dechra Pharmaceuticals PLC
LSE:DPH
Capital Expenditures
-ÂŁ30.3m
CAGR 3-Years
15%
CAGR 5-Years
-19%
CAGR 10-Years
-13%
A
Alliance Pharma PLC
LSE:APH
Capital Expenditures
-ÂŁ1.2m
CAGR 3-Years
44%
CAGR 5-Years
20%
CAGR 10-Years
13%

See Also

What is AstraZeneca PLC's Capital Expenditures?
Capital Expenditures
-4.1B USD

Based on the financial report for Jun 30, 2024, AstraZeneca PLC's Capital Expenditures amounts to -4.1B USD.

What is AstraZeneca PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-3%

Over the last year, the Capital Expenditures growth was -13%. The average annual Capital Expenditures growth rates for AstraZeneca PLC have been -25% over the past three years , -11% over the past five years , and -3% over the past ten years .

Back to Top